Header Logo

Connection

ANA MERCEDES CIUREA to Neoplasms, Second Primary

Back to Details
This is a "connection" page, showing publications ANA MERCEDES CIUREA has written about Neoplasms, Second Primary.
ANA MERCEDES CIUREA
Connection Strength
0.072
Neoplasms, Second Primary
  1. BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression. Hum Pathol. 2016 Apr; 50:79-89.
    View in: PubMed
    Score: 0.072
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.